| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-,(1S,2R)-
|
259214-55-6 |
(1S,2R)-REL-1-[[(1,1-二甲基乙氧基)羰基]氨基]-2-乙烯基-环丙羧酸
|
(1S,2R)-1-(叔丁氧羰基氨基)-2-乙烯基环丙烷羧酸;(1S,2R)-1-(叔丁氧羰基氨基)-2-乙烯基环丙烷甲酸;(1S,2R)-REL-1-[[(1,1-二甲基乙氧基)羰基]氨基]-2-乙烯基-环丙羧酸;(1S,1-二甲基乙氧基)羰基]氨基]-2-乙烯基-环丙羧酸乙酯;(1S,2R)-1-((叔丁氧基羰基)氨基)-2-乙烯基环丙烷羧酸
|
C11H17NO4 |
142.18 | |
|
(1S,2R,3S,5R)-2-((Benzyloxy)methyl)-6-oxabicyclo[3.1.0]hexan-3-ol
|
117641-39-1 |
(1S,2R,3S,5R)-2-[(苄氧甲基)-6-氧杂二环[3.1.0]己-3-醇
|
恩替卡韦杂质24;(1S,2R,3S,5R)-2-[(苄氧甲基)-6-氧杂二环[3.1.0]己-3-醇;恩替卡韦中间体2;[1S-(1Α,2Α,3Β,5Α)]-2-[(苯甲氧基)甲基];恩替卡韦-2;[IS-(1Α,2Β,3Α,5Α)]-2-[(苯甲氧基)-6-氧杂二环[3.1.0]已-3-醇;恩替卡韦杂质29
|
C13H16O3 |
220.26 | |
|
(1S,2R,3S,5R)-3-(Benzyloxy)-2-((benzyloxy)methyl)-6-oxabicyclo[3.1.0]hexane
|
110567-22-1 |
(1S,2R,3S,5R)-3-(苄氧甲基)-6-氧杂二环[3.1.0]己烷
|
恩替卡韦-3 (1S,2R,3S,5R)-3-(苯甲氧基)-2-[(苯甲氧基)甲基]-6-氧杂双环[3.1.0]己烷;恩替卡韦杂质25;(1S,5R)-3-(苄氧甲基)-6-氧杂二环[3.1.0]己烷;(1S,5R)-3-(苯甲氧基)-2-[(苯甲氧基)甲基]-6-氧杂双环[3.1.0]己烷;恩替卡韦中间体3;恩替卡韦中间体N3;(1S,5R)-3-(苄氧基)-2-[(苄氧基)甲基]-6-氧杂二环[3.1.0]己烷;(1S,5R)-2-苄氧基甲基-3-苄氧基-6-氧-二环[3.1.0]己烷
|
C20H22O3 |
310.38688 | 1592732-453-0 |
|
(1S,2S)-1,2-Di(4'-Methoxyphenyl)-1,2-diaMinoethane
|
58520-03-9 |
(1S,2S)-(-)-1,2-二(4-甲氧基苯基)-乙二胺
|
(1R,2R)-1,2-双(4-甲氧基苯基)乙二胺;(1R,2R)-双(4-甲氧基苯基)-1,2-乙二胺;(1R,2-双(4-甲氧苯基)乙二胺;(1R,2-(4-甲氧基苯基)乙二胺;(1S,2S)-1,2-二(4'-甲氧基苯基)-1,2-二苯基乙二胺;(1S,2S)-(-)-1,2-二(4-甲氧基苯基)-乙二胺;(1S,2-二(4-甲氧基苯基)乙二胺
|
C16H20N2O2 |
272.34 | |
|
(1S,2S)-(-)-1,2-Diaminocyclohexane L-tartrate
|
67333-70-4 |
(1S,2S)-(-)-1,2-环己二胺 D-酒石酸盐
|
(1S,2S)-(-)-1,2-二氨基环己烷-D-酒石酸盐;酒石酸(1S,2-环己烷二胺酯;1S,2S,环已二胺酒石酸盐;(1S,2S)-(+)-反式-1,2-环己二胺酒石酸盐;(1S,2S)-(+)-1,2-环己二胺酒石酸盐;1S,2S-环己二胺-D-酒石酸盐;(1S,2-二氨基环己烷 D-酒石酸酯;(1S,2-环己二胺 D-酒石酸盐 5G
|
C6H14N2·C4H6O6;C10H |
264.28 | 614-051-7 |
|
(1S,2S)-cyclohexane-1,2-diamine
|
21436-03-3 |
(1S,2S)-(+)-1,2-环己二胺
|
(1S,2S)-(+)-1,2-环己二胺;(1S,2-环己二胺;1S,2S-环己二胺;(1S,2-环己基二胺;(1S,2-环已二胺;(1S,2-环己二胺 10G;(1S,2-环己二胺 (奥沙利铂)
|
C6H14N2 |
114.19 | 606-765-2 |
|
(1S,2S)-(+)-2-Amino-1-phenyl-1,3-propanediol
|
28143-91-1 |
(1S,2S)-(+)-2-氨基-1-苯基-1,3-丙二醇
|
2-氨基-1-苯基-1,3-丙二醇;L-(+)-苏-2-氨基-1-苯基-1,3-丙二醇;(1S,2S)-(+)-2-氨基-1-苯基-1,3-丙二醇;左旋氨基二醇;(1S,3-丙二醇;S-氨基物;(1S,3-丙二醇,98%
|
C9H13NO2 |
167.21 | 248-867-6 |
|
(1S,2S)-N,N'-Dimethyl-1,2-cyclohexanediamine
|
87583-89-9 |
(1S,2S)-(+)-N,N'-二甲基-1,2-环己二胺
|
(1S,2S)-反式-N,N'-二甲基-1,2-环己烷二胺;(1S,2S)-(+)-1,2-双(甲氨基)环己烷;(1S,2S)-(+)-N,2-环己二胺 (奥沙利铂);(1S,N-二甲基-1,2-环己二胺 1G;(1S,N'-二甲基环己烷-1,2-二胺;(1S,N"-二甲基环己基-1,2-环己二胺;TRANS-(1S,2S)-N,N-二甲基环已二胺
|
C8H18N2 |
142.24192 | 625-342-3 |
|
(1S,2S)-(+)-N-p-Tosyl-1,2-diphenylethylenediamine
|
167316-27-0 |
(1S,2S)-(+)-N-对甲苯磺酰基-1,2-二苯基乙二胺
|
(1S,2S)-(+)-N-对甲苯磺酰基-1,2-二苯基乙二胺 (S-TS-DPEN);(1S,2S)-(+)-对甲苯磺酰基-1,2-二苯基乙二胺;(1S,2S)-N-(对甲苯磺酰)-1,2-二苯基乙二胺,98%;(1S,2S)-(-)-N-(对甲基苯磺酰基)-1,2-二苯基乙二胺 25G;(S,S)-N-(对甲苯磺酰)-1,2S)-(+)-N-(4-甲苯磺酰)-1,2-二苯基亚乙基二胺
|
C21H22N2O2S |
366.48 | |
|
(1S, 2S)-(1-BENZYL-3-CHLORO-2-HYDROXY-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER
|
165727-45-7 |
(1S,2S)-(1-苄基-3-氯-2-羟基丙基)氨基甲酸叔丁酯
|
(1S,2S)-(1-苄基-3-氯-2-羟基丙基)氨基甲酸叔丁酯;(3S)-3-(叔丁氧羰基)氨基-1-氯-4-苯基-(2S)-丁醇;(2S,3S)-3-(叔丁氧羰基氨基)-1-氯-2-羟基-4-苯基丁烷;(2S,3S)-3-(叔丁氧基羰基氨基)-1-氯-2-羟基-4-苯基丁烷
|
C15H22ClNO3 |
299.79 | 1312995-182-4 |
|
(1S,2S)-(-)-1,2-Diphenylethylenediamine
|
29841-69-8 |
(1S,2S)-1,2-二苯基乙二胺
|
(1S,2S)-(-)-1,2-二苯基-1,2-乙二胺;(1S,2S)-(+)-1,2-乙二胺,97%;(1S,2S)-二苯基乙二胺;1S,2S-二苯基乙胺;(1R)-1-苯基乙二胺;(1S)-1-苯基乙二胺;(1S,2-二氨基-1,2-二苯基乙烷;(1S,2-二苯基乙亚胺
|
C14H16N2 |
212.29 | 608-420-1 |
|
(1S,2S)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
|
21963-41-7 |
(1S,2S)-1,2-环己烷二甲酸
|
(1S,2S)-1,2-环己烷二甲酸;(1S,2-环己烷二羧酸;(1S,2S)-环己烷-1,2-二羧酸,98%;(1S,2-环已烷二甲酸;(1S
|
C8H12O4 |
172.18 | |
|
trans-2-Aminocyclo hexanol hydrochloride
|
13374-30-6 |
(1S,2S)-2-氨基环己醇盐酸盐
|
(1S,2S)-反式-2-氨基环己醇
|
C6H13NOHCl |
151.63446 | |
|
(1S,2S)-2-(Benzylamino)cyclohexanol
|
322407-34-1 |
(1S,2S)-2-苯甲氨基环己醇
|
(1S,2S)-2-苯甲氨基环己醇;反式-(1S,2S)-2-苄氨基环己醇;(1S,2S)-2-(苄氨基)环己醇;(1S,2S)-2-BENZYLAMINO-1-CYCLOHEXANOL,MIN.98%;(1S,2S)-2-(苄基氨基)环己醇
|
C11H21NO3 |
215.28934 | |
|
Lurasidone Impurity 6
|
3205-34-3 |
(1S,2S)-环己烷-1,2-二甲醇
|
(1S,2S)-环己烷-1,2-二基二甲醇;(1S,2S}-1,2-环己烷=甲醇;(1S,2-二甲醇;(1S,2S)-1,2-环己烷二甲醇
|
C8H16O2 |
144.21 | 1308068-626-2 |
|
(1S,2S,3R,5S)-(+)-2,3-Pinanediol
|
18680-27-8 |
(1S,2S,3R,5S)-(+)-2,3-蒎烷二醇
|
(1S,2S,3R,5S)-(+)-2,3-蒎烷二醇;2,3-蒎烷二醇;(1S,5S)-(+)-蒎烷二醇;(+)2,3-蒎烷二醇;(1S 2S 3R 5S)-(+)-蒎烷二;(1ALPHA,2ALPHA,3ALPHA,5ALPHA))-2,6,6-三甲基双环[3.3.1]庚烷-2,3-二醇;(1S,5S)-()-2,3-蒎醇;(+)-2-羟基异松蒎醇(1S,5S)-2,6-三甲基双环[3.1.1]庚烷-2,3-二醇
|
C10H18O2 |
170.25 | 606-096-6 |
|
methyl (1S,2S,3S,4R)-3-[(1R)-1-amino-2-ethylbutyl]-2-hydroxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopentane-1-carboxylate
|
316173-29-2 |
(1S,2S,3S,4R)-3-[(1S)-1-氨基-2-乙基丁基]-4-[叔丁氧羰基氨基]-2-羟基-环戊烷羧酸甲酯
|
帕拉米韦中间体3;(1S,2S,3S,4R)-3-[(1S)-1-氨基-2-乙基丁基]-4-[叔丁氧羰基氨基]-2-羟基-环戊烷羧酸甲酯;帕拉米韦中间体III;(1S,4R)-3-[(1S)-1-氨基-2-乙丁基]-4[[(1,1-二甲基乙氧基)羰基]氨基]-2-羟基环戊酸甲酯;帕拉米韦中间体 500G
|
C18H34N2O5 |
358.47296 | 1308068-626-2 |
|
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
|
142217-77-4 |
(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇
|
恩替卡韦4中间体;恩替卡韦杂质32;恩替卡韦中间体N4;[1S-(1Α,2Β,3Α,5Β)]-5-[2-氨基-6-(苯甲;(1S,2S,3S,5S)-5-(2-氨基-6-苄氧基-9H-嘌呤-9-基)-3-苄氧基-2-苄氧基甲基环戊醇;恩替卡韦中间体4;(1S,5S)-2-(苄氧基甲基)-3-(苄氧基)-5-[2-氨基-6-(苄氧基)-9H-嘌呤-9-基]环戊醇;恩替卡韦中间体四
|
C32H33N5O4 |
551.64 | 1312995-182-4 |
|
(1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-[(2-pyrazinylcarbonyl)amino]acetyl]amino]-3,3-dimethyl-1-oxobutyl]octahydrocyclopenta[c]pyrrole-1-carboxylic acid tert-butyl ester
|
926276-19-9 |
(1S,3AR,6AS)-2-[(2S)-2-[[(2S)-2-环己基-2-[(2-吡嗪基羰基)氨基]乙酰基]氨基]-3,3-二甲基-1-氧代丁基]八氢环戊并[C]吡咯-1-羧酸叔丁酯
|
(1S,3AR,6AS)-2-[(2S)-2-[[(2S)-2-环己基-2-[(2-吡嗪基羰基)氨基]乙酰基]氨基]-3,3-二甲基-1-氧代丁基]八氢环戊并[C]吡咯-1-羧酸叔丁酯;特拉匹韦N-3
|
C31H47N5O5 |
569.73538 | |
|
Cyclopenta[c]pyrrole-1-carboxylic acid, octahydro-, ethyl ester, hydrochloride (1:1), (1S,3aR,6aS)-
|
1147103-42-1 |
(1S,3AR,6AS)-八氢环戊烯并[C]吡咯-1-羧酸乙酯盐酸盐
|
特拉匹韦中间体1;(1S,3AR,6AS)-八氢环戊烯[C]吡咯-1-羧酸乙酯盐酸盐;特拉匹韦中间体 TL-2;(1S,6AS)-八氢环戊烯并[C]吡咯-1-羧酸乙酯;特拉匹伟 中间体2;(1S,6AS)-八氢环戊二烯并[C]吡咯-1-羧酸乙酯盐酸盐;(1S,6AS)-八氢环戊烷[C]吡咯-1-羧酸乙酯 盐酸盐;(1S,6AS)-八氢环戊烯并[C]吡咯-1-羧酸乙酯盐酸盐
|
C10H17NO2.HCl |
219.70842 |
药智官方微信
药智官方微博
